Seizure-like Hippocampal Activity in Alzheimer's Disease Neurodegeneration
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Levetiracetam (Primary)
- Indications Alzheimer's disease
- Focus Pharmacodynamics
- 23 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Jul 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2018.
- 20 Jul 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017.